J&J Partnership, page-342

First 342 Last

Share
Profile

Follow
Hotdog11

1,391 Posts.

231

12/11/21

11:10

Post #: 57523043
Share

Originally posted by bedger: ↑

I really don't think the market is connecting the dots. Lets be honest, most of the market is completely oblivious to OCC.

Johnson and Johnson began a partnership with induced pluripotent stem cells (iPSCs) company (Fate Therapeutics) to create genetically engineered, clonal master iPSC lines to produce NK-cell and T-cell products.

J&J used two embryonic stem-cell lines to develop its COVID-19 vaccines: human embryonic kidney cells called HEK 293 and human embryonic retinal cells called PER.C6.

The PER.C6 cell line creating a little media storm as it is from an elective abortion in the Netherlands in 1985, and the HEK 293 cell line comes from an undisclosed source (either spontaneous miscarriage or elective abortion) in the Netherlands in about 1972.

J&J is fairly keenly embracing stem-cell technologies. I would be amazed if a partnerhsip with OCC did not occur after the ATI results. It would be nothing for them to drop a couple of hundred million on a partnership/trial pathway that could easily lead to very quickly attainable commercialisation of a treatment with universal out-patient application.

I could be wrong, but am fairly confident I am not and the market is simply unaware of the potential, much like it was ahead of the Fate Therapeutics partnership.

Expand

Bedger, did you by any chance looking into a post from me earlier this week about

Apollo Health Venture

Dr Jen Eckstein

Himself and Apollo are big on finding and investing in the next small biotech, they invest world wide

With your knowledge of Orthocell, might be worth giving them a heads up about our company

OCC Price at posting: 49.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it